The Lancet has published on the persistent neurodegenerative and neuropsychiatric disorders of those with 'long COVID'. Brain fog is the most prevalent symptoms which we know is amenable to treatment with photobiomodulation and neurofeedback.
'The analysis, conducted by researchers at the University of Oxford and drawing on health records data from more than 1 million people around the world, found that while the risks of many common psychiatric disorders returned to normal within a couple of months, people remained at increased risk for dementia, epilepsy, psychosis and cognitive deficit (or brain fog) two years after contracting COVID19. Adults appeared to be at particular risk of lasting brain fog, a common complaint among coronavirus survivors.'
Neuronic Devices Ltd. and Quietmind Foundation are designing combined neurofeedback and photobiomodulation protocols to address the disrupted neural connectivity and tissue level neuropathological features of long COVID. We are working with our academic reserch partners to develop clinical trials that will provide the most scientifically reliable means for determining the most effective PBM treatment protocols. Our research on 1070nm photobiomodulation offe useful insights as to the biological mechanisms underlying clinical improvement from long COVID. See the attached recently published paper on this topic.
For more information on PBM for improving brain health and resistance to injury see the work being done at Prof. Paul Chazot's lab at Durham University, Quietmnidfdn.org and neuronic.online
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.